Hjem › Aterosklerose › Kansas
Aterosklerose kliniske forsøg i Kansas
5 studier for Aterosklerose søger deltagere på steder i Kansas.
Byer i Kansas
Officiel studietekst (engelsk)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Cotton O'Neil Clinical Research Center, Topeka
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Cotton-ONeil Diabetes and Endocrinology Center, Topeka
RekruttererFase 3
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Midwest Heart & Vascular Specialists, LLC, Overland Park
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07521007Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Kansas Nephrology Physicians, PA, Wichita
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Kansas City
- Research Site, Kansas City
- Research Site, Topeka
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT07000357Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.